Amisulprid-Mepha 200, Tabletten

7680595140010 CH-59514 Tabletten

Associated product:

AMISULPRID Mepha cpr 200 mg 30 pce
Amisulprid-Mepha 200, Tabletten
Amisulprid-Mepha 200, Tabletten
Amisulprid-Mepha 200, Tabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2023
Patient information leaflet
Français
09/08/2023
Patient information leaflet
Italien
09/08/2023
Summary of Product Characteristics
Allemand
06/07/2022
Summary of Product Characteristics
Français
06/07/2022
Summary of Product Characteristics
Italien
06/07/2022

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
197.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 40.50
Specialties list
Yes
Generic
Yes
SL addition date: 01/09/2010

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
59514
Drug name
Amisulprid-Mepha, Tabletten
Galenic form
TAB
ATC Code
N05AL05
Authorization status
Z
Dispensing category
B
First authorization
05/07/2010
Authorization expiration date
31/12/9999
IT Number
01.05.0.
Domain
Human medicine
Field of application
Neuroleptikum

Package details

Description (FR)
AMISULPRID Mepha cpr 200 mg 30 pce
Description (DE)
AMISULPRID Mepha Tabl 200 mg 30 Stk
Market launch
05/07/2010
Narcotic (BTM)
No

Original drug

Solian, comprimés pelliculés sécables
GTIN: 7680605050018
CHF 66.20
View original

Other package sizes (1)

AMISULPRID Mepha cpr 200 mg 90 pce
90 TABL
GTIN: 7680595140027
View